Corteva, Inc. $CTVA Shares Sold by M&T Bank Corp

M&T Bank Corp lowered its stake in shares of Corteva, Inc. (NYSE:CTVA) by 2.9% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 1,850,532 shares of the company’s stock after selling 55,322 shares during the quarter. M&T Bank Corp’s holdings in Corteva were worth $124,042,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Activest Wealth Management boosted its stake in Corteva by 118.3% during the third quarter. Activest Wealth Management now owns 369 shares of the company’s stock worth $25,000 after buying an additional 200 shares during the last quarter. JPL Wealth Management LLC acquired a new position in Corteva during the third quarter worth $25,000. True Wealth Design LLC boosted its stake in Corteva by 209.5% during the third quarter. True Wealth Design LLC now owns 390 shares of the company’s stock worth $26,000 after buying an additional 264 shares during the last quarter. Redmont Wealth Advisors LLC acquired a new position in Corteva during the third quarter worth $29,000. Finally, Jackson Grant Investment Advisers Inc. boosted its stake in Corteva by 90.6% during the third quarter. Jackson Grant Investment Advisers Inc. now owns 448 shares of the company’s stock worth $30,000 after buying an additional 213 shares during the last quarter. Institutional investors and hedge funds own 81.54% of the company’s stock.

Corteva Price Performance

CTVA stock opened at $80.97 on Monday. The company has a current ratio of 1.43, a quick ratio of 0.96 and a debt-to-equity ratio of 0.07. The company has a market capitalization of $54.36 billion, a PE ratio of 51.24, a P/E/G ratio of 2.77 and a beta of 0.59. Corteva, Inc. has a 12-month low of $60.53 and a 12-month high of $85.63. The business’s fifty day moving average price is $80.39 and its 200 day moving average price is $72.18.

Corteva (NYSE:CTVA) last posted its quarterly earnings data on Tuesday, February 3rd. The company reported $0.22 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.22. The firm had revenue of $3.91 billion for the quarter, compared to the consensus estimate of $4.23 billion. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The company’s quarterly revenue was down 1.7% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.32 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, sell-side analysts anticipate that Corteva, Inc. will post 3.62 EPS for the current year.

Corteva Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, June 15th. Investors of record on Monday, June 1st will be issued a $0.18 dividend. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. The ex-dividend date is Monday, June 1st. Corteva’s payout ratio is currently 45.57%.

Analysts Set New Price Targets

CTVA has been the topic of a number of recent research reports. Royal Bank Of Canada boosted their price objective on Corteva from $89.00 to $95.00 and gave the stock an “outperform” rating in a research note on Friday, April 24th. BNP Paribas Exane lifted their target price on Corteva from $72.00 to $74.00 in a research report on Monday, March 9th. Jefferies Financial Group lifted their target price on Corteva from $85.00 to $95.00 and gave the company a “buy” rating in a research report on Monday, March 2nd. Argus lifted their target price on Corteva from $80.00 to $91.00 and gave the company a “buy” rating in a research report on Tuesday, March 31st. Finally, Wells Fargo & Company lifted their target price on Corteva from $85.00 to $90.00 and gave the company an “overweight” rating in a research report on Tuesday, April 21st. Fourteen research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $86.38.

Insider Activity

In related news, insider Brian Titus sold 8,311 shares of the business’s stock in a transaction on Friday, February 20th. The stock was sold at an average price of $76.55, for a total value of $636,207.05. Following the sale, the insider owned 8,090 shares in the company, valued at approximately $619,289.50. The trade was a 50.67% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.15% of the company’s stock.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.